Clinical Trials Browser

INDUSTRY × balugrastim × Clear all

NCT00837265 2024-04-03

NEUGR-002

Phase 2/3 Completed

334 enrolled 16 charts

Chemotherapy-induced Neutropenia

NCT01126190 2023-03-28

NEUGR-003

Phase 3 Completed

381 enrolled 13 charts

Chemotherapy-induced Neutropenia

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors